Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

Details 詳細情報について

• CRID

  1363670319247022464

• DOI

  10.1016/j.ahj.2020.05.002

• ISSN

  00028703

• Web Site

  https://api.elsevier.com/content/article/PII:S0002870320301381?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0002870320301381?httpAccept=text/plain

• Data Source

  • Crossref